Making body wasting visible
Location: Switzerland, Geneva
Employees: 1-10
Total raised: $7.01M
Investors 3
Funding Rounds 2
| Date | Series | Amount | Investors |
| 01.07.2025 | - | $5.06M | - |
| 10.01.2022 | - | $1.95M | - |
Mentions in press and media 28
| Date | Title | Description |
| 02.07.2025 | Adiposs Secures CHF 4 Million to Revolutionize Cancer Imaging | In the world of medical innovation, every breakthrough can feel like a breath of fresh air. Adiposs, a Swiss startup, has just taken a significant step forward by securing CHF 4 million in a Series A financing round. This funding is not jus... |
| 01.07.2025 | Adiposs Raises CHF 4M to advance cancer imaging tool | Adiposs is developing ImageBAT®, a novel contrast agent that enables non-invasive CT imaging of brown adipose tissue—an early marker of treatment effectiveness. Current imaging methods cannot reliably detect this tissue. Proceeds from the r... |
| 01.07.2025 | Adiposs secures CHF 4 Million to advance clinical trials | Adiposs announced the successful closing of a CHF 4 million Series A financing round. The round was syndicated by Swiss and Taiwanese VC firms, European family offices and high-net-worth individual investors. The financing will be used for... |
| 06.09.2024 | Kickfund invests at full throttle | Kickfund Ventures Fund I is a new investment fund dedicated to enhancing Switzerland's innovation ecosystem by supporting deep tech startups have successfully participated in the Venture Kick competition. With an initial closing of CHF 70 ... |
| 13.08.2024 | Four startups from the medical field obtain the Innosuisse Certificate | After completing the Innosuisse Core Coaching program, startups can apply for the Innosuisse Certificate, to boost their track record. Upon receiving their applications, the Innosuisse Innovation Council evaluates the entries based on the ... |
| 10.10.2023 | Promising breakthroughs in healthcare | |
| 26.05.2023 | Slow developments but positive energy and enthusiasm at Startup Days | |
| 10.01.2022 | Adiposs raises CHF 1.8 million to start clinical trials and product industrialization | Adiposs raises CHF 1.8 million to start clinical trials and product industrialization 10.01.2022 14:29, Isabelle Mitchell linkedIn facebook twitter instagram youtube --> Adiposs, the developer of a unique diagnostic product for the non-i... |
| 10.01.2022 | CHF 1.8 million in first closing of Adiposs pre-Series A equity round | |
| 10.01.2022 | Adiposs raises CHF 1.8 million to start clinical trials and product industrialization | The investment round will be used to manufacture the first batch of ImageBAT, a first-in-class contrast agent for brown adipose tissue detection, as well as to perform the first-in-human clinical trial. Lucian Wagner, GP of Privilège Ventur... |
Show more